| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |